Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

TR 987

Next Previous
X
Search
Drug Profile

TR 987

Alternative Names: Glucoprime; GLYC-101; MG-3601; TR-987

Latest Information Update: 05 Sep 2021

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Glycotex; Novogen
  • Developer Glycotex; SerenaGroup; TR Therapeutics
  • Class Anti-inflammatories; Glucans
  • Mechanism of Action Dectin 1 stimulants; Macrophage stimulants; Toll-like receptor 2 modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Phase II Varicose ulcer
  • No development reported Wounds

Most Recent Events

  • 03 Sep 2021 Phase II development for Varicose ulcer is ongoing in USA (NCT03154619)
  • 03 Sep 2021 No development reported - Phase-II for Wounds in USA (Topical)
  • 15 Sep 2020 TR 987 is available for licensing as of 15 Sep 2020. http://www.trtherapeutics.com/

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top